Roche Again Extends $5.7B Offer To Illumina Shareholders
Swiss pharmaceutical company Roche Holdings AG said Monday it will extend its $5.7 billion hostile takeover offer for Illumina Inc. by another month, giving shareholders of the U.S.-based gene sequencing firm...To view the full article, register now.
Already a subscriber? Click here to view full article